Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in around 90 minutes
{{cartTotalQuantity}}
Molecular diagnostic menu
Instruments and software
Cepheid’s Solutions
Testing Everywhere
Cepheid’s Insights
Webinars
About Cepheid
Mission and History
Distributors
News
Events
Careers
Our Leadership
Support Center
Contact Us
Total
({{currency}})
0
Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in around 90 minutes
Detection of the presence of bladder cancer in patients with hematuria in around 90 minutes
GXBCRABL-US-10
Delivering MORE confidence with fast, accurate Chronic Myeloid Leukemia molecular monitoring results
View our additional portals to find documents and resources not listed here.
View our self-help articles, create a case, or view contact information.